NHSA Issues Guidelines to Strengthen Medical Insurance Payment Management
The National Healthcare Security Administration (NHSA) has released a set of guiding opinions aimed at...
Policy / Regulatory
Beijing Joins Jiangxi’s Interferon Volume-Based Procurement Initiative
The Beijing Municipal Medical Insurance Bureau has announced its participation in the Jiangxi-led interferon inter-provincial...
NMPA and NHC Tighten Regulations on Etomidate and Modafinil
The National Medical Products Administration (NMPA) and the National Health Commission (NHC) have jointly issued...
Guangdong Medicine Exchange Announces Volume-Based Procurement for Medical Devices
The Guangdong Medicine Exchange has issued three notifications regarding the volume-based procurement (VBP) of medical...
Shanghai Boosts Community Healthcare with Enhanced Reimbursement and Services
Shanghai’s healthcare security administration has announced a comprehensive set of measures aimed at enhancing community...
Beijing Insurance Bureau Launches Pilot to Boost Access to NRDL Drugs
The Beijing Municipal Medical Insurance Bureau has announced the initiation of pilot work aimed at...
Beijing-Tianjin-Hebei Region Initiates Drug VBP with 37 Medicines, Including Biologics
The Beijing Municipal Medical Insurance Bureau has issued a notification to commence the drug volume-based...
Hunchun Port Designated as Medical Materials Import Port by NMPA and GAC
The National Medical Products Administration (NMPA) and the General Administration of Customs have jointly released...
CDE Introduces New Guidelines for Generic Drug Quality and Efficacy Consistency Evaluation
The Center for Drug Evaluation (CDE) has released a new set of Guidelines for “the...
EU Chamber of Commerce in China Releases Position Paper, Addresses Pharma and Healthcare
The EU Chamber of Commerce in China has released its bi-annual “European Business in China...
CDE Releases 74th Batch of Generic Reference Preparations with 58 New Specifications
The Center for Drug Evaluation (CDE) has released the 74th batch of chemical generic reference...
China’s NHC Expands Rare Disease List, Includes 21 Cancer Types
The National Health Commission (NHC) of China has released an updated national list of rare...
NHSA Clears Retagliptin and Ambroxol for National Reimbursement Drug List Inclusion
The National Healthcare Security Administration (NHSA) has completed a review of the National Reimbursement Drug...
China’s CDE Proposes Removal of Ambroxol Inhalation Solution and Four Other Drugs
The Center for Drug Evaluation has issued a notification concerning the Chemical Generic Drug Reference...
NMPA Drafts Quality Management Norms for Online Medical Device Sales
The National Medical Products Administration (NMPA) has issued the “Medical Device Online Sales Quality Management...
NMPA Seeks Comments on Medical Device Classification Draft Proposal
The National Medical Products Administration (NMPA) has issued a notification focusing on the definition and...
China Launches Fourth National Volume-Based Procurement Tender Focusing on Medical Consumables
The national high-value medical consumables joint procurement office has released a notification, marking the commencement...
NHSA Unveils Measures to Enhance Smart Monitoring and Auditing of Basic Medical Insurance Funds
The National Healthcare Security Administration (NHSA) has released a notification detailing planned measures to improve...
NMPA Pilots Priority Review for Rare Disease Formula Foods, Aims to Reduce Approval Time
The National Medical Products Administration (NMPA) has initiated a pilot program to implement “Priority review...
China Updates Narcotics and Psychotropic Substances Catalog, Adds Three Substances
The National Medical Products Administration (NMPA), Ministry of Public Security, and National Health Commission have...